Zacks Small Cap Research on MSN
RADX: RAD101: Imaging Recurring Brain Metastases
RADX READ THE FULL RADX RESEARCH REPORT Radiopharm Theranostics Limited (NASDAQ:RADX) held another key opinion leader (KOL) ...
News Medical on MSN
ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...
News-Medical.Net on MSN
Five-session SBRT reduces side effects in intermediate-risk prostate cancer
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
Dr. Lilach O. Lerman's Renovascular Research Lab at Mayo Clinic studies functional MRI and other imaging to assess renal and cardiac hemodynamics and renal fibrosis.
The 2025 ASTRO annual meeting featured a prostate cancer radiation toxicity session and a presentation by Dr. Young Suk Kwon discussing an EPIC-26 longitudinal analyses of prostatic urethral lift ...
No patients died of prostate cancer. The 5-year overall survival was 90%.
VCU Massey Comprehensive Cancer Center continues to lead the way with MRI-guided radiation therapy, now in prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback